$1.63
9.44% yesterday
Nasdaq, Oct 17, 10:15 pm CET
ISIN
US1570851014
Symbol
CERS

Cerus Corporation Stock price

$1.63
-0.34 17.26% 1M
-0.01 0.61% 6M
-0.53 24.54% YTD
+0.31 23.48% 1Y
-4.46 73.23% 3Y
-2.82 63.37% 5Y
-2.42 59.75% 10Y
Nasdaq, Closing price Thu, Oct 17 2024
-0.17 9.44%
ISIN
US1570851014
Symbol
CERS
Sector

Key metrics

Market capitalization $302.03m
Enterprise Value $330.32m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.94
P/S ratio (TTM) P/S ratio 1.78
P/B ratio (TTM) P/B ratio 6.10
Revenue growth (TTM) Revenue growth 10.79%
Revenue (TTM) Revenue $169.98m
EBIT (operating result TTM) EBIT $-39.01m
Free Cash Flow (TTM) Free Cash Flow $-27.08m
Cash position $71.19m
EPS (TTM) EPS $-0.13
P/E forward negative
P/S forward 1.52
EV/Sales forward 1.66
Short interest 5.07%
Show more

Is Cerus Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,907 stocks worldwide.

Cerus Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Cerus Corporation forecast:

4x Buy
67%
2x Hold
33%

Analyst Opinions

6 Analysts have issued a Cerus Corporation forecast:

Buy
67%
Hold
33%

Financial data from Cerus Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
170 170
11% 11%
100%
- Direct Costs 77 77
13% 13%
45%
93 93
9% 9%
55%
- Selling and Administrative Expenses 70 70
13% 13%
41%
- Research and Development Expense 60 60
16% 16%
35%
-37 -37
45% 45%
-22%
- Depreciation and Amortization 2.44 2.44
46% 46%
1%
EBIT (Operating Income) EBIT -39 -39
45% 45%
-23%
Net Profit -24 -24
53% 53%
-14%

In millions USD.

Don't miss a Thing! We will send you all news about Cerus Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cerus Corporation Stock News

Neutral
Business Wire
one day ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) today announced updates on the INTERCEPT red blood cell (RBC) programs in the U.S. and in Europe: U.S. – New $248 million BARDA contract supports program beyond U.S. Phase 3 studies through anticipated PMA licensure and into commercialization Europe – CE Mark review has been concluded without approval; assessing strategy for anti...
Neutral
Seeking Alpha
3 months ago
Cerus Corporation (NASDAQ:CERS ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Jessica Hanover - VP, Corporate Affairs Obi Greenman - President & CEO Vivek Jayaraman - COO Kevin Green - CFO Conference Call Participants Ross Osborne - Cantor Fitzgerald Jacob Johnson - Stephens Eric Anderson - TD Cowen Vidyun Bais - BTIG William Bonello - Craig-Hallum Capital Gro...
Neutral
Business Wire
3 months ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced financial results for its second quarter and six months ended June 30, 2024. Total revenue for the three and six months ended June 30, 2024 was comprised of (in thousands, except %): Three Months Ended   Six Months Ended June 30, Change June 30, Change 2024 2023 $ % 2024 2023 $ % Product Revenue $ 45,079 $ 38,853...
More Cerus Corporation News

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Head office United States
CEO Obi Greenman
Employees 288
Founded 1991
Website www.cerus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today